Takeda -Revisiting treatment success in Crohn’s disease (Takeda Pharmaceuticals International AG)

Presented by

Premium Content

Please purchase any of the premium collections shown to access this library item.


View all of your premium content purchases in myUEG > My Learning.
If you need help or have questions, please contact e-learning@ueg.eu


This item was part of the Takeda -Revisiting treatment success in Crohn’s disease (Takeda Pharmaceuticals International AG) session at UEG Week 2019

You may be interested in:

Similarities and differences between CD and UC: A pathogenetic approach to IBD
English, Presentation, Colon, Investigation and Diagnosis, Inflammatory bowel disease, Host defence, immune reactions, 2010

Categorisation:

  • Company
    • Takeda Pharmaceuticals International AG
  • Format
    • Industry Sponsored Symposia
    • Presentation
  • Language
    • English
  • UEG Week Pathway
    • Industry Sponsored Symposia
  • Year
    • 2019